CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of Gardasil (V501) Given Concomitantly With REPEVAX™ in Healthy Adolescents 11-17 Years of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00337428
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:22.790516+00:00
Published At: 2010-02-11T00:00:00+00:00
Record Updated At: 2016-11-16
Results Posted At: 2010-02-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neoplasms, Glandular and Epithelial", "Diphtheria", "Tetanus", "Whooping Cough", "Poliomyelitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-11-16"
protocolSection.identificationModule.nctId: "NCT00337428"
protocolSection.identificationModule.officialTitle: "An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of Gardasil (V501) Given Concomitantly With REPEVAX\u2122 in Healthy Adolescents 11-17 Years of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2010-02-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.